ABBV-2222

ABBV-2222 is a CFTR corrector being studied for the treatment of cystic fibrosis (CF).

Type of Molecule

Small Molecule

Target

CTFR

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Cystic Fibrosis n/a
Phase 2